The Department of Health and Social Care’s UK Vaccine Network funded Future Vaccine Manufacturing Research Hubs, FVMR Hub and Vax-Hub held a webinar “Vaccine manufacturing during a global pandemic".
![Vaccine manufacturing webinar screenshot 10 June 2021 Vaccine manufacturing webinar screenshot 10 June 2021](/biochemical-engineering/sites/biochemical_engineering/files/styles/large_image/public/ll_event_group.jpg?itok=JKpA09QQ)
During the event, which featured leading COVID-19 vaccine scientists and policy-makers, participants explored the role of academia in vaccine manufacturing innovation, discussed the UK's positioning in global health research and international development, and reflected on the lessons learnt from the COVID-19 pandemic to shape future research in this area.Ìý
Proceedings were held across three sessions and questions addressed during the day included:Ìý
- How has progress (e.g. in vaccine platform technologies) influenced the development of vaccines? To what extent have pandemic preparedness strategies supported the development of a vaccine?Ìý
- What role does local vaccine manufacturing capacity play in equitable access to vaccines and can long-term availability and supply of vaccines be improved by investing in additional local production capacity in low and middle-income countries?Ìý
- What role does UK-based vaccine manufacturing research play in ensuring global health security against future pandemics and how can we strengthen our capacity and contribution?Ìý
Chairs: Martina Micheletti and Marta Mauri (Vax-Hub) Speakers: Steve Bagshaw (Vaccines Taskforce Programme, BEIS), Robin Shattock (FVMR Hub), Sarah Gilbert (Vax-Hub)
Ìý
Ìý
Ìý
Chairs: Ben Pierce and Parisa Meysami (FVMR Hub) Speakers: Matthew Duchars (VMIC), Mike Whelan (CEPI) Additional panellists: Gordon Dougan (University of Cambridge), Brendan Wren (LSHTM)
In the third session, we discussed the technological and policy innovations necessary to provide enhanced health security, both nationally and globally. We reflected on the UK’s vaccine development and manufacturing infrastructures within a global health context and the ways in which we can work with LMIC manufacturers to develop processes that improve the local response to serious diseases before they become global emergencies.
Please contact us for further informationÌýaboutÌýthis event and our future programme.ÌýÌý